Silver Spring-based United Therapeutics Corp. has been clear about its ambitions to build an unlimited supply of certain transplantable organs.
Now, founder Martine Rothblatt said the company's new multiyear collaboration with a 3-D bioprinting company, takes it a big step toward that goal.
United Therapeutics (NASDAQ: UTHR), which now mostly develops and sells pulmonary hypertension drugs, announced a development agreement to create "solid-organ scaffolds" for human transplants with Rock Hill, South Carolina-based 3D Systems (NYSE: DDD).
Image: Martine Rothblatt of United Therapeutics has previously touted a goal of manufacturing an unlimited supply of transplantable human organs. - http://www.bizjournals.com
